Compression therapy affects collagen type balance in hypertrophic scar

Area of Science:

• Biomedical Engineering
• Dermatology
• Tissue Engineering

Background:

• The impact of pressure on hypertrophic scar development remains unclear.
• Reduced extracellular matrix deposition is a proposed mechanism for pressure therapy's effects.
• Investigating collagen composition is crucial for understanding pressure therapy in scar management.

Purpose of the Study:

• To analyze collagen composition in hypertrophic scars under pressure therapy.
• To quantify changes in collagen precursors and types I and III.
• To elucidate the role of collagen modulation in scar formation and treatment.

Main Methods:

• Hypertrophic scars in red Duroc swine (n=8) underwent pressure treatment (30 mm Hg), sham treatment, or no treatment for 2 weeks.
• Scars were assessed weekly, with biopsies for histology, hydroxyproline quantification, and gene expression (COL1A2, COL3A1).
• Collagen quantification utilized Masson trichrome staining and immunofluorescence for collagen types I and III.

Main Results:

• Hydroxyproline assay revealed a 51.9% decrease in total collagen after pressure initiation.
• Masson trichrome and immunofluorescence showed significant reductions in collagen types I and III in pressure-treated scars compared to controls (P < 0.05).
• Collagen 1A2 and 3A1 transcript levels decreased significantly (41.9- and 42.3-fold, respectively) after pressure treatment.

Conclusions:

• Pressure therapy effectively modulates collagen deposition in hypertrophic scars.
• The findings demonstrate pressure's role in reducing key collagen components.
• This study provides a deeper understanding of pressure therapy's mechanism in scar treatment.